Stocks and Investing Stocks and Investing
Fri, March 22, 2024
Thu, March 21, 2024

Geulah Livshits Maintained (TSHA) at Strong Buy with Increased Target to $7 on, Mar 21st, 2024


Published on 2024-10-28 09:50:11 - WOPRAI, Geulah Livshits
  Print publication without navigation


Geulah Livshits of Chardan Capital, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy with Increased Target from $5 to $7 on, Mar 21st, 2024.

Geulah has made no other calls on TSHA in the last 4 months.



There are 3 other peers that have a rating on TSHA. Out of the 3 peers that are also analyzing TSHA, 0 agree with Geulah's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Geulah


  • Gil Blum of "Needham" Maintained at Strong Buy with Increased Target to $7 on, Wednesday, March 20th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $7 on, Wednesday, March 20th, 2024
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Wednesday, March 20th, 2024
Contributing Sources